|
US5470571A
(en)
|
1988-01-27 |
1995-11-28 |
The Wistar Institute |
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
|
|
FR2660556B1
(fr)
|
1990-04-06 |
1994-09-16 |
Rhone Poulenc Sante |
Microspheres, leur procede de preparation et leur utilisation.
|
|
IL98528A0
(en)
|
1990-06-21 |
1992-07-15 |
Merck & Co Inc |
Pharmaceutical compositions containing hybrid for killing bladder cancer cells
|
|
CZ283717B6
(cs)
|
1991-03-06 |
1998-06-17 |
MERCK Patent Gesellschaft mit beschränkter Haftung |
Chimérická monoklonální protilátka, expresní vektory a farmaceutický prostředek
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5498421A
(en)
|
1993-02-22 |
1996-03-12 |
Vivorx Pharmaceuticals, Inc. |
Composition useful for in vivo delivery of biologics and methods employing same
|
|
US20030133955A1
(en)
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
JP3423317B2
(ja)
|
1993-07-19 |
2003-07-07 |
アンジオジェネシス テクノロジーズ インコーポレイテッド |
抗−血管形成性組成物およびそれにより被覆されたステント
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
|
EP0739203A4
(en)
|
1994-01-14 |
2000-12-20 |
Cell Therapeutics Inc |
METHOD OF TREATING CELL PROLIFERATION CONDITIONS IN RESPONSE TO PDGF, EGF, FGF AND VEGF
|
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
|
US5744460A
(en)
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
|
ATE314843T1
(de)
|
1996-03-12 |
2006-02-15 |
Pg Txl Co Lp |
Wasserlösliche paclitaxel-prodrogen
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
NZ333657A
(en)
|
1996-07-30 |
2000-05-26 |
Novartis Ag |
A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
ATE293640T1
(de)
|
1997-04-07 |
2005-05-15 |
Genentech Inc |
Anti-vegf antikörper
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
CA2765222C
(en)
*
|
1997-06-27 |
2017-05-09 |
Abraxis Bioscience, Llc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
SG113402A1
(en)
|
1997-06-27 |
2005-08-29 |
American Bioscience Inc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6258084B1
(en)
|
1997-09-11 |
2001-07-10 |
Vnus Medical Technologies, Inc. |
Method for applying energy to biological tissue including the use of tumescent tissue compression
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
DE69934681T2
(de)
|
1998-04-16 |
2007-11-08 |
Eurovita A/S |
Neue synergistische zusammensetzungen, die aromatische verbindungen und in alpinia galanga vorhandene terpenoide enthalten
|
|
EP1100494A1
(en)
|
1998-07-30 |
2001-05-23 |
Novopharm Biotech, Inc. |
Pharmaceutically composition comprising an aqueous solution of paclitaxel and albumin
|
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
|
AU777528B2
(en)
|
1999-04-22 |
2004-10-21 |
Abraxis Bioscience, Llc |
Long term administration of pharmacologically active agents
|
|
WO2000071079A2
(en)
|
1999-05-21 |
2000-11-30 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
MXPA01011981A
(es)
|
1999-05-24 |
2003-09-04 |
Sonus Pharma Inc |
Vehiculo de emulsion para farmacos poco solubles.
|
|
EP1267913A2
(en)
|
1999-11-12 |
2003-01-02 |
EntreMed, Inc. |
Methods for administration of therapeutic agents on an antiangiogenic schedule
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
CA2406484A1
(en)
|
2000-04-10 |
2001-10-18 |
Moshe Flashner-Barak |
Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
US7157466B2
(en)
|
2000-06-30 |
2007-01-02 |
Smithkline Beecham (Cork) Limited |
Quinazoline ditosylate salt compounds
|
|
WO2002009696A1
(en)
|
2000-07-28 |
2002-02-07 |
Sloan-Kettering Institute For Cancer Research |
Methods for treating cell proliferative disorders and viral infections
|
|
WO2002024179A2
(en)
|
2000-09-22 |
2002-03-28 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
|
EP1353693B1
(en)
|
2001-01-16 |
2005-03-16 |
Glaxo Group Limited |
Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer
|
|
US6548531B2
(en)
|
2001-02-09 |
2003-04-15 |
Hoffmann-La Roche Inc. |
Method for cancer therapy
|
|
GB0103668D0
(en)
|
2001-02-15 |
2001-03-28 |
Biointeractions Ltd |
Methods and clinical devices for the inhibition or prevention of mammalian cell growth
|
|
KR20030081496A
(ko)
|
2001-03-06 |
2003-10-17 |
브리스톨-마이어스 스큅 컴퍼니 |
테가푸르, 우라실, 폴린산, 파클리탁셀 및 카르보플라틴투여를 통한 종양 치료 방법 및 이들의 투여 형태
|
|
WO2002069949A2
(en)
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
|
US6752922B2
(en)
|
2001-04-06 |
2004-06-22 |
Fluidigm Corporation |
Microfluidic chromatography
|
|
US7638161B2
(en)
|
2001-07-20 |
2009-12-29 |
Applied Materials, Inc. |
Method and apparatus for controlling dopant concentration during BPSG film deposition to reduce nitride consumption
|
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US20040033271A1
(en)
|
2001-12-03 |
2004-02-19 |
Seth Lederman |
Methods for contemporaneous administration of levamisole and 5-fluorouracil
|
|
US20040143004A1
(en)
|
2002-02-26 |
2004-07-22 |
Joseph Fargnoli |
Metronomic dosing of taxanes
|
|
ITMI20020680A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
ITMI20020681A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
US20040126400A1
(en)
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
AU2003251955A1
(en)
|
2002-07-16 |
2004-02-02 |
Sonus Pharmaceuticals, Inc. |
Platinum compound
|
|
GEP20074134B
(en)
|
2002-08-19 |
2007-06-25 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases
|
|
US20040047835A1
(en)
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
US20050095267A1
(en)
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
|
KR20120068035A
(ko)
|
2002-12-09 |
2012-06-26 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
|
JP2006524632A
(ja)
|
2002-12-09 |
2006-11-02 |
アメリカン バイオサイエンス、インコーポレイテッド |
組成物及び薬物送達方法
|
|
KR20050098244A
(ko)
|
2003-01-10 |
2005-10-11 |
쓰레솔드 파마슈티컬스, 인코포레이티드 |
2-데옥시글루코오스를 사용한 암 치료 방법
|
|
JP2006523235A
(ja)
|
2003-03-28 |
2006-10-12 |
コーザン バイオサイエンシス インコーポレイテッド |
再狭窄を予防するための装置、方法及び組成物
|
|
WO2005000266A2
(en)
|
2003-05-22 |
2005-01-06 |
Neopharm, Inc. |
Liposomal formulations comprising a combination of two or more active agents
|
|
US20050026893A1
(en)
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
|
RS20160203A1
(sr)
|
2003-05-30 |
2016-10-31 |
Genentech Inc |
Tretman sa anti-vegf antitelima
|
|
AR046510A1
(es)
|
2003-07-25 |
2005-12-14 |
Regeneron Pharma |
Composicion de un antagonista de vegf y un agente anti-proliferativo
|
|
JP2007505938A
(ja)
|
2003-09-23 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
Ｖｅｇｆ受容体阻害剤と化学療法剤の組み合わせ
|
|
EP2286794B8
(en)
|
2003-10-15 |
2016-06-01 |
SynCore Biotechnology CO., LTD |
Use of cationic liposomes comprising paclitaxel
|
|
WO2005042539A1
(en)
|
2003-10-29 |
2005-05-12 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20050203174A1
(en)
|
2004-03-09 |
2005-09-15 |
Kosan Biosciences, Inc. |
Combination therapies using leptomycin B
|
|
WO2005090372A2
(en)
|
2004-03-15 |
2005-09-29 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
WO2006001911A2
(en)
|
2004-05-06 |
2006-01-05 |
Genentech, Inc. |
Crystal structure of the hepatocyte growth factor beta chain and methods of use
|
|
US8420603B2
(en)
|
2004-05-14 |
2013-04-16 |
Abraxis Bioscience, Llc |
SPARC and methods of use thereof
|
|
AU2006249235B2
(en)
|
2004-05-14 |
2010-11-11 |
Abraxis Bioscience, Llc |
Sparc and methods of use thereof
|
|
BRPI0511126A
(pt)
|
2004-05-14 |
2007-11-27 |
Abraxis Bioscience Inc |
métodos de tratamento utilizando proteìnas de ligação de albumina como alvos
|
|
RU2404810C9
(ru)
|
2004-06-01 |
2015-06-20 |
Дженентек, Инк. |
Конъюгаты антитело-лекарственное средство и способы
|
|
EP1753455A2
(en)
|
2004-06-04 |
2007-02-21 |
Genentech, Inc. |
Method for treating multiple sclerosis
|
|
GT200500155A
(es)
|
2004-06-16 |
2006-05-15 |
|
Terapia del càncer resistente al platino
|
|
US8772269B2
(en)
|
2004-09-13 |
2014-07-08 |
Eisai R&D Management Co., Ltd. |
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
CA2598510C
(en)
|
2005-02-18 |
2011-12-20 |
Abraxis Bioscience, Inc. |
Q3 sparc deletion mutant and uses thereof
|
|
KR20070114753A
(ko)
|
2005-02-18 |
2007-12-04 |
아브락시스 바이오사이언스 인크. |
치료제의 조합 및 투여 방식, 및 조합 요법
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
CA2598441A1
(en)
|
2005-02-24 |
2006-08-31 |
Elan Pharma International Limited |
Nanoparticulate formulations of docetaxel and analogues thereof
|
|
CN101232901B
(zh)
|
2005-02-28 |
2011-12-07 |
卫材R&D管理有限公司 |
磺酰胺化合物和血管生成抑制物质的联合新应用
|
|
JP5700909B2
(ja)
|
2005-05-04 |
2015-04-15 |
メディゲーネ アクチエンゲゼルシャフトＭｅｄｉＧｅｎｅ ＡＧ |
パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
|
|
US20080221135A1
(en)
|
2005-05-13 |
2008-09-11 |
Bristol-Myers Squibb Company |
Combination therapy
|
|
KR101457834B1
(ko)
|
2005-08-31 |
2014-11-05 |
아브락시스 바이오사이언스, 엘엘씨 |
증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조 방법
|
|
TR200801336T1
(tr)
|
2005-08-31 |
2008-08-21 |
Abraxis Bioscience, Inc. |
Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
|
|
US8007995B2
(en)
|
2005-11-10 |
2011-08-30 |
Bristol-Myers Squibb Company |
Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
|
|
WO2007059116A2
(en)
|
2005-11-14 |
2007-05-24 |
Abraxis Bioscience, Inc. |
Geldanamycin derivatives and pharmaceutical compositions thereof
|
|
CA2922029C
(en)
|
2006-03-22 |
2017-11-28 |
Medigene Ag |
A combination of a cationic liposomal preparation comprising an antimitotic agent and a non-liposomal preparation comprising an antimitotic agent
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
JP2010502603A
(ja)
|
2006-08-31 |
2010-01-28 |
アブラクシス バイオサイエンス， エルエルシー |
血管形成を阻害し、血管形成関連疾患を処置する方法
|
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
AU2007334360B2
(en)
|
2006-12-14 |
2013-10-17 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
RU2483714C2
(ru)
|
2007-03-07 |
2013-06-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи. |
Наночастица, содержащая рапамицин и альбумин, в качестве противоракового агента
|
|
CN101678078B
(zh)
|
2007-04-13 |
2014-12-10 |
阿布拉西斯生物科学公司 |
Sparc及其使用方法
|
|
WO2008137148A2
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
|
PT2155188E
(pt)
|
2007-06-01 |
2013-12-19 |
Abraxis Bioscience Llc |
Métodos e composições para o tratamento de cancro recorrente
|
|
KR20100044780A
(ko)
|
2007-06-15 |
2010-04-30 |
유니버시티 오브 사우스 플로리다 |
암의 진단 및 치료 방법
|
|
US20090018078A1
(en)
|
2007-07-09 |
2009-01-15 |
Vinod Labhasetwar |
Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same
|
|
CA2721153C
(en)
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
KR20150136137A
(ko)
|
2008-04-10 |
2015-12-04 |
아브락시스 바이오사이언스, 엘엘씨 |
소수성 탁산 유도체의 조성물 및 그의 용도
|
|
WO2010068925A1
(en)
|
2008-12-11 |
2010-06-17 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
US20120189701A1
(en)
|
2009-03-13 |
2012-07-26 |
Desai Neil P |
Combination therapy with thiocolchicine derivatives
|
|
EP2416650B1
(en)
|
2009-04-10 |
2020-02-26 |
Abraxis BioScience, LLC |
Nanoparticle formulations and uses therof
|
|
SMT201900751T1
(it)
|
2009-04-15 |
2020-03-13 |
Abraxis Bioscience Llc |
Composizioni nanoparticellari prive di prioni e metodi
|
|
ES2577024T3
(es)
|
2009-08-25 |
2016-07-12 |
Abraxis Bioscience, Llc |
Terapia combinada con composiciones de nanopartículas de taxano e inhibidores de Hedgehog
|
|
ES2675212T3
(es)
|
2010-03-26 |
2018-07-09 |
Abraxis Bioscience, Llc |
Métodos de tratamiento de carcinoma hepatocelular
|
|
US10660965B2
(en)
|
2010-03-29 |
2020-05-26 |
Abraxis Bioscience, Llc |
Methods of enhancing drug delivery and effectiveness of therapeutic agents
|
|
US9393318B2
(en)
|
2010-03-29 |
2016-07-19 |
Abraxis Bioscience, Llc |
Methods of treating cancer
|
|
KR20130109025A
(ko)
|
2010-06-02 |
2013-10-07 |
아브락시스 바이오사이언스, 엘엘씨 |
방광암의 치료 방법
|
|
MX347225B
(es)
|
2010-06-04 |
2017-04-19 |
Abraxis Bioscience Llc * |
Metodos de tratamiento contra el cancer pancreatico.
|
|
KR101850566B1
(ko)
|
2010-06-07 |
2018-04-19 |
아브락시스 바이오사이언스, 엘엘씨 |
증식성 질환의 치료를 위한 조합 치료 방법
|
|
ES2819204T3
(es)
|
2011-04-28 |
2021-04-15 |
Abraxis Bioscience Llc |
Administración intravascular de composiciones de nanopartículas y usos de las mismas
|
|
US9585960B2
(en)
|
2011-12-14 |
2017-03-07 |
Abraxis Bioscience, Llc |
Use of polymeric excipients for lyophilization or freezing of particles
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
JP6388880B2
(ja)
|
2013-02-11 |
2018-09-12 |
アブラクシス バイオサイエンス， エルエルシー |
メラノーマの治療方法
|
|
ES2804323T3
(es)
|
2013-03-12 |
2021-02-05 |
Abraxis Bioscience Llc |
Procedimientos de tratamiento de cáncer de pulmón
|
|
HK1219231A1
(zh)
|
2013-03-13 |
2017-03-31 |
阿布拉科斯生物科学有限公司 |
治疗儿童实体瘤的方法
|
|
SG11201507234UA
(en)
|
2013-03-14 |
2015-10-29 |
Abraxis Bioscience Llc |
Methods of treating bladder cancer
|